ResearcherHarvard UniversityActive in the last 2 years

Marsha A Moses

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3108-0704; OpenAlex author ID A5028523107; NIH RePORTER profile ID 1933571. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 1
Labs led: 1
Collaborators: 1

Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 grant

Papers 1

A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. Last author DOI 10.1002/advs.202002852 ↗

Grants 1

Engineered exosome mimetics as targeted biological nanomedicines for pancreatic cancer R21CA283420 ↗

Closest collaborators

The 1 strongest of 1 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jing Huang · 1 shared paper, 2020 · strength 0.16
- Paper A Rationally Designed ICAM1 Antibody Drug Conjugate for Pancreatic Cancer. DOI 10.1002/advs.202002852 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.